Literature DB >> 31095994

The effects of vitamin D supplementation on mental health, and biomarkers of inflammation and oxidative stress in patients with psychiatric disorders: A systematic review and meta-analysis of randomized controlled trials.

Hamidreza Jamilian1, Elaheh Amirani2, Alireza Milajerdi3, Fariba Kolahdooz4, Hamed Mirzaei5, Marsa Zaroudi6, Amir Ghaderi7, Zatollah Asemi8.   

Abstract

BACKGROUND: In the current meta-analysis of randomized controlled trials (RCTs), the effects of vitamin D supplementation on mental health, and biomarkers of inflammation and oxidative stress in patients with psychiatric disorders are assessed.
METHODS: The following databases were search up to March 2019: MEDLINE, EMBASE, Web of Science, and Cochrane Central Register of Controlled Trials. The quality of the relevant extracted data was assessed according to the Cochrane risk of bias tool. Data were pooled by the use of the inverse variance method and expressed as mean difference with 95% Confidence Intervals (95% CI).
RESULTS: Eleven effect sizes from nine studies were included in the final analyses. A pooled analysis of 9 effect sizes showed a significant reduction in Beck Depression Inventory (BDI) score following supplementation with vitamin D [weighted mean difference (WMD): -3.91; 95% CI: -5.15 -2.66), I2= 85.9%]. Combining data from two available studies on the effects of vitamin D supplementation on Pittsburgh Sleep Quality Index (PSQI) also revealed a significant reduction in this score following the intervention (WMD: -1.78; 95% CI: -2.28, -1.28). In addition, there were significant increase in glutathione (GSH) through 3 studies (WMD: 180.70; 95% CI: 6.76, 354.64), and in total antioxidant capacity (TAC) through 3 studies (WMD: 90.09; 95% CI: 56.36, 123.82) after vitamin D supplementation. Combining data from five studies, we found a significant reduction in C-reactive protein (CRP) concentrations after vitamin D supplementation (WMD: -1.74; 95% CI: -2.82, -0.66).
CONCLUSIONS: Overall, the current meta-analysis demonstrated that taking vitamin D supplements among patients with psychiatric disorders had beneficial effects on BDI, PSQI, GSH, TAC and CRP levels, but did not affect other biomarkers of inflammation and oxidative stress.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammation; Meta-analysis; Oxidative stress; Psychiatric disorders; Vitamin D supplementation

Mesh:

Substances:

Year:  2019        PMID: 31095994     DOI: 10.1016/j.pnpbp.2019.109651

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  18 in total

1.  Exploring the effect of vitamin D3 supplementation on surrogate biomarkers of cholesterol absorption and endogenous synthesis in patients with type 2 diabetes-randomized controlled trial.

Authors:  Huicui Meng; Nirupa R Matthan; Edith Angellotti; Anastassios G Pittas; Alice H Lichtenstein
Journal:  Am J Clin Nutr       Date:  2020-09-01       Impact factor: 7.045

2.  [Bipolar disorder vulnerability: The vitamin D path].

Authors:  Manel Naifar; Manel Maalej Bouali; Wassim Guidara; Ahmed Slim Ellouze; Khalil Jmal; Sana Omri; Meriam Messedi; Lobna Zouari; Aida Elleuch; Mohamed Maalej; Khansa Chaabouni; Nada Charfi; Mouna Turki; Ben Thabet Jihène; Fatma Ayadi
Journal:  Can J Psychiatry       Date:  2019-08-21       Impact factor: 4.356

3.  The use of dietary supplements for mental health among the Saudi population: A cross-sectional survey.

Authors:  Deemah Alateeq; Maha A Alsubaie; Faridah A Alsafi; Sultanah Hisham Alsulaiman; Ghazwa B Korayem
Journal:  Saudi Pharm J       Date:  2022-03-29       Impact factor: 4.562

Review 4.  Exposure to greenspaces could reduce the high global burden of pain.

Authors:  Jessica Stanhope; Martin F Breed; Philip Weinstein
Journal:  Environ Res       Date:  2020-05-08       Impact factor: 6.498

5.  Low Omega-3 intake is associated with high rates of depression and preterm birth on the country level.

Authors:  Timothy H Ciesielski; Scott M Williams
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

Review 6.  Vitamin D in the time of the coronavirus (COVID-19) pandemic - a clinical review from a public health and public mental health perspective.

Authors:  Ursula Werneke; Fiona Gaughran; David M Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2021-07-09

7.  Inflammation and the Association of Vitamin D and Depressive Symptomatology.

Authors:  Ezgi Dogan-Sander; Roland Mergl; Anja Willenberg; Ronny Baber; Kerstin Wirkner; Steffi G Riedel-Heller; Susanne Röhr; Frank M Schmidt; Georg Schomerus; Christian Sander
Journal:  Nutrients       Date:  2021-06-08       Impact factor: 5.717

8.  Prognosis in metastatic lung cancer: vitamin D deficiency and depression-a cross-sectional analysis.

Authors:  Daniel C McFarland; Madalyn Fernbach; William S Breitbart; Christian Nelson
Journal:  BMJ Support Palliat Care       Date:  2020-08-27       Impact factor: 4.633

9.  Serum 25-hydroxyvitamin D levels and psychological distress symptoms in patients with affective disorders during the COVID-19 pandemic.

Authors:  Marco Di Nicola; Luigi Dattoli; Lorenzo Moccia; Maria Pepe; Delfina Janiri; Andrea Fiorillo; Luigi Janiri; Gabriele Sani
Journal:  Psychoneuroendocrinology       Date:  2020-09-14       Impact factor: 4.905

10.  Course of depressive symptomatology and its association with serum uric acid in one-anastomosis gastric bypass patients.

Authors:  Eva Winzer; Bernhard Ludvik; Igor Grabovac; Renate Kruschitz; Karin Schindler; Gerhard Prager; Carmen Klammer; Friedrich Hoppichler; Rodrig Marculescu; Maria Wakolbinger
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.